| |
PRIMA BIOMED LTD Company Summary |
|
| Prima Biomed (ASX: PRR) is a biotechnology company based in Sydney, Australia. The Company is focused on technologies in the fields of immunology and cancer immunotherapy. Prima is focused on developing a dendritic-cell based immunotherapy targeting mucin-1 tumour expressed antigen. Prima's lead product, CVac(tm) has completed Phase IIa clinical development in Ovarian Cancer and is working to a path of US FDA IND approval. |
|
|
|
 |
Headquarters |
Suite 1705, 109 Pitt St |
 |
| |
|
Sydney NSW 2000 AUSTRALIA |
|
|
Telephone |
+61 2 9232 4420 |
|
|
Fax |
+61 2 9232 4450 |
|
|
Principal Sector |
Health & Pharm |
|
|
Principal Industry |
Biotechnology |
|
|
Listed |
1988/06/23 |
|
|
Homepage |
www.primabiomed.com.au |
|
| |
|
|
|
| Stock Exchange | Stock Code |  ASX:PRR | PRR | | | | | | | |
|
| |
NEWS |
 |
|
|
